These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35313109)

  • 21. CRISPR/Cas gene therapy.
    Zhang B
    J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR-Cas9 technology: A new direction for personalized medicine in respiratory disease?
    Vaughan A; Yang IA
    Respirology; 2019 Jul; 24(7):614-615. PubMed ID: 31033105
    [No Abstract]   [Full Text] [Related]  

  • 23. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
    Duroux-Richard I; Giovannangeli C; Apparailly F
    Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
    [No Abstract]   [Full Text] [Related]  

  • 25. Cas9 immunity creates challenges for CRISPR gene editing therapies.
    Crudele JM; Chamberlain JS
    Nat Commun; 2018 Aug; 9(1):3497. PubMed ID: 30158648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic applications of CRISPR RNA-guided genome editing.
    Koo T; Kim JS
    Brief Funct Genomics; 2017 Jan; 16(1):38-45. PubMed ID: 27562951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virus-Based CRISPR/Cas9 Genome Editing in Plants.
    Liu H; Zhang B
    Trends Genet; 2020 Nov; 36(11):810-813. PubMed ID: 32828551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases.
    Sharma G; Sharma AR; Bhattacharya M; Lee SS; Chakraborty C
    Mol Ther; 2021 Feb; 29(2):571-586. PubMed ID: 33238136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease.
    Baker C; Hayden MS
    F1000Res; 2020; 9():281. PubMed ID: 32528662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editors.
    Boucher P; Cui X; Curiel DT
    J Control Release; 2020 Nov; 327():788-800. PubMed ID: 32891680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges.
    Pei WD; Zhang Y; Yin TL; Yu Y
    Brief Funct Genomics; 2020 May; 19(3):215-228. PubMed ID: 31819946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The current CRISPR methods.
    Lei H; Liu GS
    Methods; 2021 Oct; 194():1-2. PubMed ID: 34389459
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recent progresses in CRISPR genome editing in plants].
    Li H; Xie K
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1700-1711. PubMed ID: 29082718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-Cas9 Probing of Infectious Diseases and Genetic Disorders.
    Ramalingam S; Thangavel S
    Indian J Pediatr; 2019 Dec; 86(12):1131-1135. PubMed ID: 31367975
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
    Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Gene Editing Technique in Xenotransplantation.
    Naeimi Kararoudi M; Hejazi SS; Elmas E; Hellström M; Naeimi Kararoudi M; Padma AM; Lee D; Dolatshad H
    Front Immunol; 2018; 9():1711. PubMed ID: 30233563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mini review: genome and transcriptome editing using CRISPR-cas systems for haematological malignancy gene therapy.
    Elliott EK; Haupt LM; Griffiths LR
    Transgenic Res; 2021 Apr; 30(2):129-141. PubMed ID: 33609253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.